Menopause & HRT  

OBGYN.net Menopause & Perimenopause
OBGYN.net Osteoporosis

ACOG: Adding Androgen To Estrogen Therapy Can Yield Benefits
Adding small amounts of androgen to estrogen replacement therapy can restore failing libido, resolve persistent hot flashes and increase bone density, all side effects of menopause that can affect quality of life and health for millions of post-menopausal women. These findings and others were presented at the American College of Obstetricians and Gynecologists annual meeting in New Orleans.
 

Post-Menopausal Women With Cystic Ovarian Cancer Not In Grave Danger, Says Study
Should a post-menopausal woman, over the age of 50, who has been diagnosed with cystic ovarian tumors, be alarmed? According to conclusions reached in a new study published in the April issue of Gynecologic Oncology, alarm is unwarranted, but concern is appropriate.
 

Raloxifine Not As Effective As HRT In Improving Heart Disease Risk Factors
A drug to prevent osteoporosis is also effective in lowering risk factors for cardiovascular disease in post-menopausal women, but is not as effective as hormone replacement therapy (HRT), according to an
article in The Journal of the American Medical Association.
 

The Menopausal Patient and Hormone Replacement Therapy 1995
Menopause is the irreversible cessation of the female reproductive cycle and menses, which follows from a permanent loss of ovarian response to gonadotropins. This change generally occurs spontaneously between the ages of 45 and 55 in American women, with an average age of 51.
 

Menopausal Hormone Replacement Therapy and Cancer Risk
Replacement hormones (estrogen or a combination of estrogen and progestin) have been shown to be effective in relieving conditions usually related to menopause.
 

The North American Menopause Society
The NAMS Web Site objective is to reach people who need accurate, unbiased information about menopause.
 
Its possible negative impact on the survival of patients with a previous diagnosis of breast, uterine, or ovarian cancer remains controversial. The risk/benefit analysis of hormone replacement therapy in this setting warrants further investigation.
 

Hormone Replacement Therapy and Breast Cancer
A statement by the Australasian Menopause Society on HRT and breast cancer